1S90

1S90

Healthcare · EUR · F

1S90

Price

€6.523

+2.03%

Cap

€74.57M

Earnings

30d Trend

-11.0%

1S90
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityHigh

107% annualised over 90 days

BRAIN47 SIGNAL

0
WEAK
Risk Level85
Quality47
Momentum35
Technical42
Fundamentals50

Raw weighted: 37×Macro 0.99 (1%)=37

RISK

85/100
90d Volatility
107.4%High
ATR %
6.7%High daily moves
Max Drawdown (1Y)
-75.4%Volatile

QUALITY

47/100
ROE (avg)
12.9%Good
Piotroski F-Score
5/9Average
Debt/Equity
2.49High leverage
Accruals
3.3%Accrual heavy

MOMENTUM

35/100
12-1M Momentum
-0.6%Downtrend
6-1M Momentum
-65.4%Negative
1M Return
+7.5%Strong recent gains

TECHNICAL

42/100
RSI (14)
44.1Neutral
Price vs SMA200
-45.6%Bearish trend
MACD
+0.03Bullish momentum
Bollinger Band
32%Mid-range
SMA Cross
Golden CrossGolden Cross
Trend Quality (KER)
0.129Noisy/choppy

FUNDAMENTALS

50/100

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 80%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months57
3-12 months26
1-5+ years46

Limited short-term thesis

BRAIN47'S ASSESSMENT

I rate 1S90 at 37/100 — a WEAK reading on the Brain47 Signal. The strongest factor is fundamentals at 50/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.

PAST PERFORMANCE

1 MONTH

+7.5%

3 MONTHS

-13.3%

12 MONTHS

+6.9%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Limited short-term thesis. Fundamentals (50) and Quality (47) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 107%. I classify this as a speculative position — elevated volatility at 107% and smaller market cap define the opportunity.

speculativeScore: 37/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.